Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,082 public trials 2,050 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL

NCT02518113

Conditions
Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +11 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • Memorial Sloan Kettering Cancer Center New York, United States
View all 22 locations
View Trial Details
Completed

Fludarabine Phosphate, Low-Dose Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

NCT00005799

Conditions
Accelerated Phase Chronic Myelogenous Leukemia, Adenocarcinoma, Adult Acute Lymphoblastic Leukemia in Remission, +105 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • University of Colorado Denver, Colorado, United States
  • Baylor University Medical Center Dallas, Texas, United States
View Trial Details
Completed

Open-Label, Non Randomized Phase 2 Study With Safety Run-In

NCT02249429

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • Weill Cornell Medicine New York, United States
  • University Clinical Center Republic of Srpska Banja Luka, Bosnia and Herzegovina
  • University Clinical Center Sarajevo Sarajevo, Bosnia and Herzegovina
  • Insitute Curie Saint-Cloud, Paris, France
View Trial Details
Completed

Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHL

NCT00369707

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
  • Hematology-Oncology Associates of Illinois Chicago, Illinois, United States
  • Northwestern University Chicago, Illinois, United States
  • Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details

Related conditions